Fusion Proteins and Combination Vaccines Comprising Haemophilus Influenzae Protein E and Pilin A
GlaxoSmithKline Biologicals S.A.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application PCT/CA2012/050236, filed Apr 12, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,945,577 | Fusion Proteins and Combination Vaccines Comprising Haemophilus Influenzae Protein E and Pilin A In force · High confidence UsedRemaining | GlaxoSmithKline Biologicals S.A. | In force | High confidence | ||
| US 9,296,794 | Fusion Proteins and Combination Vaccines Comprising Haemophilus Influenzae Protein E and Pilin A In force · Medium confidence | GlaxoSmithKline Biologicals S.A. | In force | Medium confidence | ||
| US 10,023,616 | Fusion Proteins and Combination Vaccines Comprising Haemophilus Influenzae Protein E and Pilin A In force · Medium confidence | GlaxoSmithKline Biologicals S.A. | In force | Medium confidence | ||
| US 10,730,917 | Fusion Proteins and Combination Vaccines Comprising Haemophilus Influenzae Protein E and Pilin A In force · Medium confidence | GlaxoSmithKline Biologicals S.A. | In force | Medium confidence | ||
| US 11,198,707 | Fusion Proteins and Combination Vaccines Comprising Haemophilus Influenzae Protein E and Pilin A In force · Medium confidence | GlaxoSmithKline Biologicals S.A. | In force | Medium confidence | ||
| US 10,214,569 | Fusion Proteins and Combination Vaccines Comprising Haemophilus Influenzae Protein E and Pilin A In force · Medium confidence | GlaxoSmithKline Biologicals S.A. | In force | Medium confidence | ||
| US 9,409,957 | Fusion Proteins and Combination Vaccines Comprising Haemophilus Influenzae Protein E and Pilin A In force · Medium confidence | GlaxoSmithKline Biologicals S.A. | In force | Medium confidence |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.